Stock Movers: Moderna Plunges, Celsius Surges, Newsmax Soars on IPO

Biotech Sector Uncertainty

• 📉 Moderna shares fell over 7%, reaching their lowest point since March 2020, as a key US FDA regulator resigned.
• ⚠️ The departure of Peter Marks, who oversaw vaccine and medication approvals, has created uncertainty regarding the future of vaccines and gene therapies.
• 📊 The broader S&P Biotech ETF also saw a decline of about 4%, indicating a sector-wide nervousness.
• 🗣️ Analysts noted that while the new FDA commissioner's confirmation was positive, the politicization of the FDA is a concern.

Celsius Holdings' Growth Strategy

• 📈 Celsius Holdings experienced a significant rise, hitting its highest level since September following an upgrade by Truist Securities.
• 🎯 The upgrade was based on Celsius's acquisition of Alani Nu, which is expected to strengthen its position in the women's energy drink segment.
• 🚀 Despite a short interest of nearly 20%, Celsius has shown strong performance, up 35% year-to-date, and has seen substantial growth in previous years.

Newsmax's Explosive IPO Debut

• 🚀 Newsmax shares skyrocketed, surging as much as 683% on their debut session after its initial public offering.
• 💰 The conservative media outlet raised $75 million by selling 7.5 million shares at $10 each.
• 📈 The stock's performance, including multiple halts for volatility, suggests significant individual investor interest.
• ⚠️ The IPO's success for a loss-making cable news network contrasts with other recent, less successful high-profile IPOs.
• 📊 Newsmax was among the 30 most actively traded stocks on Fidelity's platform, indicating strong retail participation.